Research programme: immunotherapeutic kinoids and toxoids - Neovacs

Drug Profile

Research programme: immunotherapeutic kinoids and toxoids - Neovacs

Alternative Names: Conjugated vaccines - NeoVacs; Debio 0512; E7 toxoid; E7 Δ21-26 toxoid; huTNFα kinoid; iCore toxoid; IL-10 kinoid; IL-4 kinoid; Interleukin-4 kinoid; Vascular endothelial growth factor kinoid; VEGF-kinoid

Latest Information Update: 04 Nov 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Neovacs
  • Developer Debiopharm; Neovacs
  • Class Vaccines
  • Mechanism of Action Immunomodulators; Immunostimulants; Interleukin 4 inhibitors; Vascular endothelial growth factor A inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Hypersensitivity
  • No development reported Age-related macular degeneration; Solid tumours
  • Discontinued Cachexia; Hepatitis C; Human papillomavirus infections

Most Recent Events

  • 04 Nov 2017 No recent reports of development identified for preclinical development in Age-related-macular-degeneration in France (IM)
  • 04 Nov 2017 No recent reports of development identified for preclinical development in Solid-tumours in France
  • 05 Jan 2017 NeoVacs and Sunnybrook Research Institute of Toronto enter into an agreement to collaborate for preclinical development of VEGF Kinoid for Colorectal and Ovarian cancers
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top